Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

O Sander

Showing results (1-10 of 153) with videos related to

Pageof 16
Sort By:
Zeitschrift Fur Rheumatologie|November 11, 2010
[The safety of biologics : a risk-benefit assessment of treating rheumatoid arthritis with biologics based on registry data on mortality]O Sander
International Journal of Clinical Pharmacology and Therapeutics|December 16, 1998
Clinical trials on biologics in rheumatoid arthritisO Sander, R Rau
Zeitschrift Fur Rheumatologie|May 6, 2018
[Rheumatology in the mirror : How do we see ourselves and how are we seen?]O Sander, M Schneider
Zeitschrift Fur Rheumatologie|December 29, 1998
[Therapy of refractory chronic polyarthritis with tumor necrosis factor alpha receptor fusion protein (TNFR55-IgG1)--long term follow-up of 80 personal cases]O Sander, R Rau
Deutsche Medizinische Wochenschrift (1946)|June 7, 2007
[Temporal arteritis]O Sander, M Schneider
Zeitschrift Fur Rheumatologie|December 29, 1998
[Treatment of chronic polyarthritis with a human recombinant interleukin 1 receptor antagonist]R Rau, O Sander, P Musikic
Klinische Padiatrie|May 14, 2014
Autoinflammatory diseases (AID)G Dueckers, O Sander, T Niehues
Annals of the Rheumatic Diseases|June 18, 2003
Erosion healing in rheumatoid arthritis after anakinra treatmentR Rau, O Sander, S Wassenberg
Zeitschrift Fur Rheumatologie|May 5, 1998
[Is H15 (resin extract of Boswellia serrata, "incense") a useful supplement to established drug therapy of chronic polyarthritis? Results of a double-blind pilot study]O Sander, G Herborn, R Rau
Acta Anaesthesiologica Scandinavica|September 13, 2003
Equivalence of hydroxyethyl starch HES 130/0. 4 and HES 200/0. 5 for perioperative volume replacement in major gynaecological surgeryO Sander, K Reinhart, A Meier-Hellmann
Pageof 16

Showing results (1-10 of 153) with videos related to

Sort By:
Pageof 16
Zeitschrift Fur Rheumatologie|November 11, 2010
[The safety of biologics : a risk-benefit assessment of treating rheumatoid arthritis with biologics based on registry data on mortality]O Sander
International Journal of Clinical Pharmacology and Therapeutics|December 16, 1998
Clinical trials on biologics in rheumatoid arthritisO Sander, R Rau
Zeitschrift Fur Rheumatologie|May 6, 2018
[Rheumatology in the mirror : How do we see ourselves and how are we seen?]O Sander, M Schneider
Zeitschrift Fur Rheumatologie|December 29, 1998
[Therapy of refractory chronic polyarthritis with tumor necrosis factor alpha receptor fusion protein (TNFR55-IgG1)--long term follow-up of 80 personal cases]O Sander, R Rau
Deutsche Medizinische Wochenschrift (1946)|June 7, 2007
[Temporal arteritis]O Sander, M Schneider
Zeitschrift Fur Rheumatologie|December 29, 1998
[Treatment of chronic polyarthritis with a human recombinant interleukin 1 receptor antagonist]R Rau, O Sander, P Musikic
Klinische Padiatrie|May 14, 2014
Autoinflammatory diseases (AID)G Dueckers, O Sander, T Niehues
Annals of the Rheumatic Diseases|June 18, 2003
Erosion healing in rheumatoid arthritis after anakinra treatmentR Rau, O Sander, S Wassenberg
Zeitschrift Fur Rheumatologie|May 5, 1998
[Is H15 (resin extract of Boswellia serrata, "incense") a useful supplement to established drug therapy of chronic polyarthritis? Results of a double-blind pilot study]O Sander, G Herborn, R Rau
Acta Anaesthesiologica Scandinavica|September 13, 2003
Equivalence of hydroxyethyl starch HES 130/0. 4 and HES 200/0. 5 for perioperative volume replacement in major gynaecological surgeryO Sander, K Reinhart, A Meier-Hellmann
Pageof 16